Unlike humans, rats have a greater capacity for spontaneous recovery after spinal cord injury, which allowed researchers to compare natural healing with healing supported by electrical stimulation.

After someone experiences a spinal cord injury, doctors set off on a race against the clock. Within a few hours, they rush patients into surgery and administer anti-inflammatory drugs, ranging ...

The FDA has issued a Class I recall of Abbott Medical’s implantable Abbott Proclaim neurostimulation systems, designed to deliver low-intensity electrical impulses to nerve structures for spinal cord ...

The latest regulatory nod covers all of the spinal cord stimulators that Abbott currently offers in the U.S., including its rechargeable Eterna and recharge-free Proclaim devices.

The US Food and Drug Administration (FDA) has approved the Abbott Proclaim XR spinal cord stimulation (SCS) system to treat painful diabetic peripheral neuropathy (DPN), a debilitating complication of ...

The FDA has approved the Proclaim XR spinal cord stimulation system for treatment of People Living with Painful Diabetic Peripheral Neuropathy. The Proclaim XR SCS system can provide relief to ...

The new indication for Abbott's Proclaim™ XR SCS system provides a non-medication option for people with painful diabetic peripheral neuropathy Spinal cord stimulation is proven to be more ...

(RTTNews) - Abbott Laboratories, Inc. (ABT) announced Thursday that the U.S. Food and Drug Administration (FDA) has approved its Proclaim XR spinal cord stimulation (SCS) system to treat painful ...